Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 5/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19317498 | 0.85 | TRPV1 (0.49) | TRPV1CA12CA1CA2CA9 | |
| SCHEMBL2294326 | 0.84 | HTR2A (0.52) | HTR2ATAAR1CA12CA1CA2 | |
| SCHEMBL29758521 | 0.84 | HTR2A (0.52) | HTR2ATAAR1CA12CA1CA2 | |
| SCHEMBL14416271 | 0.81 | HMGCR (0.58) | TRPV1HTR2ATAAR1ALOX5PTGS2 | |
| SCHEMBL5351939 | 0.80 | TAAR1 (0.62) | ALOX15HTR2ATAAR1HTR2C | |
| SCHEMBL1096991 | 0.79 | GAA (0.53) | TRPV1CA12CA1CA2CA9 | |
| SCHEMBL1096417 | 0.78 | MTNR1A (0.49) | TRPV1CA12CA1CA2CA9 | |
| SCHEMBL17169780 | 0.77 | ALOX5 (0.48) | ALOX15ALOX12ALOX5PTGS2 | |
| SCHEMBL19361333 | 0.77 | ALOX5 (0.48) | HTR2ATAAR1ALOX5PTGS2HTR2C | |
| SCHEMBL18475740 | 0.77 | TRPV1 (0.49) | ALOX15ALOX12TRPV1HTR2ATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102399231-A | Preparation method of galanthamine | BIOCOMPOUNDS PHARMACEUTICAL INC | 2012-04-04 | — | — | CN | disclosed |
| EP-1032559-A4 | AMINOALKYLPHENOL DERIVATIVES AND RELATED COMPOUNDS | AVENTIS PHARMA INC (US) | 2005-05-25 | — | — | EP | disclosed |
| US-6479495-B1 | SIMULTANEOUSLY TREATING DEPRESSION AND MEMORY DYSFUNCTION IN MAMMALS SUFFERING FROM MEMORY DYSFUNCTION AND DEPRESSION | AVENTIS PHARMACEUTICALS INC. | 2002-11-12 | — | — | US | disclosed |
| EP-1032559-A1 | AMINOALKYLPHENOL DERIVATIVES AND RELATED COMPOUNDS | AVENTIS PHARMACEUTICALS INC. (US) | 2000-09-06 | — | — | EP | disclosed |
| WO-1999016746-A1 | AMINOALKYLPHENOL DERIVATIVES AND RELATED COMPOUNDS | AVENTIS PHARMACEUTICALS INC. (US) | 1999-04-08 | — | — | WO | disclosed |